Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,387.48
(
-0.28%
)
US TECH 100
28,140.40
(
-0.76%
)
Dow Jones
49,420.12
(
-0.21%
)
Brent Oil
106.46
(
-0.94%
)
Bitcoin
76,562.55
(
-1.09%
)
News Focus
News Focus
Post# of 257581
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

acgood

Send PM Follow Ignore
Followers 17
Posts 1093
Boards Moderated 0
Alias Born 05/12/2007

acgood

Re: iwfal post# 141438

Monday, 05/07/2012 2:26:32 PM

Monday, May 07, 2012 2:26:32 PM

Post# of 257581
two notes re crizotinib+ganetespib trial

-These trials are not company sponsored. Combo trial is initiating now at MSKCC
-The single agent ALK+ trial will include ex-US sites in Europe, Asia where crizotinib not yet approved, whihc should have more robust enrollment demand.

Opinions and comments may have been previously posted @BioDueDiligence, at www.biotechduediligence.com, or disseminated to Chimera Research Group subscribers.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today